Skip to main content

Advertisement

Log in

Re: Cho et al. “Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation”

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cho HJ, Lee TG, Han SY, Kim HS, Kim JH, Han JI, Lew YJ, Kim JW (2015) Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-015-2993-3

    Google Scholar 

  2. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106(44):18751–18756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D’Amore PA (2008) VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205:491–501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ambati J, Ambati B, Yoo S, Ianchulev S, Adamis A (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293

    Article  PubMed  Google Scholar 

  5. Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF (2015) Comparison of age-related macular degeneration treatments trials research group. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(4):809–816

    Article  PubMed  Google Scholar 

  6. Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, CATT Research Group (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121(1):150–161

    Article  PubMed  Google Scholar 

  7. Kim JH, Kim JR, Kang SW, Kim SJ, Ha HS (2013) Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 155:743–749

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Each author warrants that he has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article. Furthermore, our research was not funded from any of the following organizations: National Institutes of Health (NIH); Howard Hughes Medical Institute (HHMI); and other(s).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akin Cakir.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cakir, A., Duzgun, E. Re: Cho et al. “Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation”. Graefes Arch Clin Exp Ophthalmol 254, 1425–1426 (2016). https://doi.org/10.1007/s00417-016-3268-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3268-3

Keywords

Navigation